{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:58:25Z","timestamp":1787803105953,"version":"build-2784847793"},"reference-count":101,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), is associated with several hepatobiliary manifestations, most importantly primary sclerosing cholangitis (PSC). The association between these entities is bidirectional, though not necessarily causal, making the underlying pathogenesis challenging to decipher. While not yet fully elucidated, current evidence suggests that genetic and immunological factors play key roles in the coexistence of IBD and PSC. In this review, we aim to provide a comprehensive analysis from a clinical perspective, evaluating the association between PSC, PSC-associated cholangiocarcinoma, orthotopic liver transplantation for PSC, IBD, colitis-associated neoplasia and restorative proctocolectomy with ileal pouch-anal anastomosis for UC. Despite efforts of data collection through population-based registries, much of the existing evidence is based on small cohorts, often with low event rates and limited follow-up durations. This makes it challenging to draw definitive conclusions. Acknowledging the variability and heterogeneity of prior studies, we aim to offer valuable insight for gastroenterologists and hepatologists managing this unique and often challenging scenario, which some authors consider a new entity: PSC-IBD. Longitudinal studies with extended follow-up periods are needed to better understand the disease course of PSC and UC, including the impact of medical therapy, the development, surveillance and management of neoplasia, and the outcomes of surgery for both bowel and liver diseases.<\/jats:p>","DOI":"10.1136\/egastro-2025-100199","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T02:35:19Z","timestamp":1754879719000},"page":"e100199","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical association between inflammatory bowel disease and primary sclerosing cholangitis: what changes after colectomy and liver transplantation?"],"prefix":"10.1136","volume":"3","author":[{"given":"Shanshan","family":"Wang","sequence":"first","affiliation":[{"name":"The Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy, New York-Presbyterian\/Columbia University Irving Medical Center, New York city, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Farokhian","sequence":"additional","affiliation":[{"name":"The Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy, New York-Presbyterian\/Columbia University Irving Medical Center, New York city, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7229-4840","authenticated-orcid":false,"given":"Bo","family":"Shen","sequence":"additional","affiliation":[{"name":"The Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy, New York-Presbyterian\/Columbia University Irving Medical Center, New York city, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"2025081719094970000_3.3.e100199.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.09.031"},{"key":"2025081719094970000_3.3.e100199.2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22938"},{"key":"2025081719094970000_3.3.e100199.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.038"},{"key":"2025081719094970000_3.3.e100199.4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933561"},{"key":"2025081719094970000_3.3.e100199.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.046615"},{"key":"2025081719094970000_3.3.e100199.6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac187"},{"key":"2025081719094970000_3.3.e100199.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.037"},{"key":"2025081719094970000_3.3.e100199.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.07.005"},{"key":"2025081719094970000_3.3.e100199.9","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7247238","article-title":"A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J Immunol Res"},{"key":"2025081719094970000_3.3.e100199.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.08.039"},{"key":"2025081719094970000_3.3.e100199.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1506330"},{"key":"2025081719094970000_3.3.e100199.12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329524"},{"key":"2025081719094970000_3.3.e100199.13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10214-6"},{"key":"2025081719094970000_3.3.e100199.14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/gastro\/gov007","article-title":"Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn\u2019s colitis","volume":"4","author":"Navaneethan","year":"2016","journal-title":"Gastroenterol Rep"},{"key":"2025081719094970000_3.3.e100199.15","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e3182802893"},{"key":"2025081719094970000_3.3.e100199.16","unstructured":"Berg R . Mechanisms in the pathogenesis of enteric diseases 2. Boston, MA: Springer US, 1999."},{"key":"2025081719094970000_3.3.e100199.17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(59)90098-4","article-title":"THE LIVER IN ULCERATIVE COLITIS TREATMENT OF PERICHOLANGITIS WITH TETRACYCLINE","volume":"274","author":"Rankin","year":"1959","journal-title":"The Lancet"},{"key":"2025081719094970000_3.3.e100199.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310500"},{"key":"2025081719094970000_3.3.e100199.19","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000334"},{"key":"2025081719094970000_3.3.e100199.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07374-9"},{"key":"2025081719094970000_3.3.e100199.21","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21699"},{"key":"2025081719094970000_3.3.e100199.22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0000000000002510","article-title":"Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"35","author":"Sayed","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ibd\/izz209","article-title":"Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience","volume":"26","author":"Wang","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025081719094970000_3.3.e100199.24","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1097\/DCR.0000000000001496","article-title":"Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts","volume":"62","author":"Cordes","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"2025081719094970000_3.3.e100199.25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon","volume":"16","author":"Krugliak Cleveland","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.10.020"},{"key":"2025081719094970000_3.3.e100199.29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","article-title":"Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study","volume":"5","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.30","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31822bbcc1"},{"key":"2025081719094970000_3.3.e100199.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.02.009"},{"key":"2025081719094970000_3.3.e100199.32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313213"},{"key":"2025081719094970000_3.3.e100199.33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315235"},{"key":"2025081719094970000_3.3.e100199.34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1055\/a-1031-7657","article-title":"Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline \u2013 Update 2019","volume":"51","author":"Bisschops","year":"2019","journal-title":"Endoscopy"},{"key":"2025081719094970000_3.3.e100199.35","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20497"},{"key":"2025081719094970000_3.3.e100199.36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000503341","article-title":"Long-Term Outcomes after Endoscopic Submucosal Dissection for Ulcerative Colitis-Associated Dysplasia","volume":"102","author":"Matsumoto","year":"2021","journal-title":"Digestion"},{"key":"2025081719094970000_3.3.e100199.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.02.002"},{"key":"2025081719094970000_3.3.e100199.38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2468-1253(20)30394-0","article-title":"Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group","volume":"6","author":"Shen","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.39","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e318217eea7"},{"key":"2025081719094970000_3.3.e100199.40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/gastro\/gou085","article-title":"Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"3","author":"Kochhar","year":"2015","journal-title":"Gastroenterol Rep"},{"key":"2025081719094970000_3.3.e100199.41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ecco-jcc\/jjab025","article-title":"Systematic Review and Meta-analysis of Outcomes After Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis and Ulcerative Colitis","volume":"15","author":"Barnes","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2025081719094970000_3.3.e100199.42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00384-011-1140-9","article-title":"The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis","volume":"26","author":"Rahman","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"2025081719094970000_3.3.e100199.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.10.008"},{"key":"2025081719094970000_3.3.e100199.44","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.2.234"},{"key":"2025081719094970000_3.3.e100199.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.006"},{"key":"2025081719094970000_3.3.e100199.46","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21594"},{"key":"2025081719094970000_3.3.e100199.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208450"},{"key":"2025081719094970000_3.3.e100199.48","first-page":"S69","article-title":"Management of Acute and Chronic Pouchitis","volume":"65","author":"Tome","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"2025081719094970000_3.3.e100199.49","first-page":"S106","article-title":"Management of Primary Sclerosing Cholangitis and Extraintestinal Disorders in Patients With Ileal Pouches: A Systematic Review","volume":"67","author":"Shen","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"2025081719094970000_3.3.e100199.50","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/ecco-jcc\/jjx090","article-title":"Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis","volume":"11","author":"Coletta","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2025081719094970000_3.3.e100199.51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/gastro\/goab004","article-title":"Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis","volume":"9","author":"Shen","year":"2021","journal-title":"Gastroenterol Rep"},{"key":"2025081719094970000_3.3.e100199.52","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4254\/wjh.v13.i12.2113","article-title":"Use of oral vancomycin in children with autoimmune liver disease: A single centre experience","volume":"13","author":"Di Giorgio","year":"2021","journal-title":"World J Hepatol"},{"key":"2025081719094970000_3.3.e100199.53","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.31560","article-title":"Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"key":"2025081719094970000_3.3.e100199.54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316599"},{"key":"2025081719094970000_3.3.e100199.55","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17936"},{"key":"2025081719094970000_3.3.e100199.56","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae189","article-title":"Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures","volume":"19","author":"Quraishi","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2025081719094970000_3.3.e100199.57","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/ibd\/izae257","article-title":"The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review","volume":"31","author":"Arbabzada","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"2025081719094970000_3.3.e100199.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2005.07.014"},{"key":"2025081719094970000_3.3.e100199.59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4292\/wjgpt.v4.i3.61","article-title":"Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy","volume":"4","author":"Treeprasertsuk","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"2025081719094970000_3.3.e100199.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.03.011"},{"key":"2025081719094970000_3.3.e100199.61","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6655-5"},{"key":"2025081719094970000_3.3.e100199.62","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S2468-1253(22)00039-5","article-title":"Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium","volume":"7","author":"Kiran","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.63","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00101-1"},{"key":"2025081719094970000_3.3.e100199.64","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.163"},{"key":"2025081719094970000_3.3.e100199.65","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ibd\/izx096","article-title":"Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis","volume":"24","author":"Mouchli","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2025081719094970000_3.3.e100199.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.006"},{"key":"2025081719094970000_3.3.e100199.67","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/MIB.0000000000000830","article-title":"Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation","volume":"22","author":"Kochhar","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2025081719094970000_3.3.e100199.68","doi-asserted-by":"publisher","DOI":"10.1023\/A:1017951632444"},{"key":"2025081719094970000_3.3.e100199.69","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6210"},{"key":"2025081719094970000_3.3.e100199.70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/liv.13947","article-title":"Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients","volume":"39","author":"Rompianesi","year":"2019","journal-title":"Liver Int"},{"key":"2025081719094970000_3.3.e100199.71","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/TP.0000000000001725","article-title":"Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis","volume":"101","author":"Mouchli","year":"2017","journal-title":"Transplantation"},{"key":"2025081719094970000_3.3.e100199.72","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081719094970000_3.3.e100199.73","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.crohns.2011.11.020","article-title":"Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn\u2019s disease","volume":"6","author":"Navaneethan","year":"2012","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"2025081719094970000_3.3.e100199.74","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000058744.34965.38"},{"key":"2025081719094970000_3.3.e100199.75","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0528-5"},{"key":"2025081719094970000_3.3.e100199.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.018"},{"key":"2025081719094970000_3.3.e100199.77","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318196d018"},{"key":"2025081719094970000_3.3.e100199.78","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049156"},{"key":"2025081719094970000_3.3.e100199.79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015431","article-title":"Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study","volume":"24","author":"Rennebaum","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025081719094970000_3.3.e100199.80","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13154"},{"key":"2025081719094970000_3.3.e100199.81","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12072-022-10356-1","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study","volume":"16","author":"Tan","year":"2022","journal-title":"Hepatol Int"},{"key":"2025081719094970000_3.3.e100199.82","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jhbp.952","article-title":"Prognosis of primary sclerosing cholangitis according to age of onset","volume":"28","author":"Watanabe","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2025081719094970000_3.3.e100199.83","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1080\/14656566.2024.2407022","article-title":"Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis","volume":"25","author":"Pinnuck","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"2025081719094970000_3.3.e100199.84","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.cgh.2023.01.014","article-title":"Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study","volume":"21","author":"Schregel","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719094970000_3.3.e100199.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.02.014"},{"key":"2025081719094970000_3.3.e100199.86","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100045","article-title":"Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review","volume":"2","author":"Villard","year":"2024","journal-title":"eGastroenterology"},{"key":"2025081719094970000_3.3.e100199.87","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"2025081719094970000_3.3.e100199.88","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00288-4"},{"key":"2025081719094970000_3.3.e100199.89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2025081719094970000_3.3.e100199.90","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14393"},{"key":"2025081719094970000_3.3.e100199.91","first-page":"277","article-title":"Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis","volume":"11","author":"Ong","year":"2018","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2025081719094970000_3.3.e100199.92","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ueg2.12388","article-title":"Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis","volume":"11","author":"Lundberg B\u00e5ve","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"2025081719094970000_3.3.e100199.93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04067.x"},{"key":"2025081719094970000_3.3.e100199.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.04.015"},{"key":"2025081719094970000_3.3.e100199.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.001"},{"key":"2025081719094970000_3.3.e100199.96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081719094970000_3.3.e100199.97","doi-asserted-by":"crossref","DOI":"10.1007\/s10151-024-02976-6","article-title":"Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis","volume":"28","author":"Schabl","year":"2024","journal-title":"Tech Coloproctol"},{"key":"2025081719094970000_3.3.e100199.98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100599","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"key":"2025081719094970000_3.3.e100199.99","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3748\/wjg.v24.i43.4939","article-title":"Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease","volume":"24","author":"Bajer","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2025081719094970000_3.3.e100199.100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081719094970000_3.3.e100199.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.005"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2025-100199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:12:30Z","timestamp":1755483150000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2025-100199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,10]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/egastro-2025-100199"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2025-100199","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}